Sutro Biopharma (STRO) Interest Coverage Ratio (2017 - 2025)
Sutro Biopharma (STRO) reported Interest Coverage Ratio of 2.46 for Q3 2025, up 69.99% on a YoY basis from 1.45 in Q3 2024, and down 1526.67% sequentially from 0.15 in Q2 2025.
Sutro Biopharma (STRO) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Interest Coverage Ratio data on file, last reported at 2.46 in Q3 2025.
- For the quarter ending Q3 2025, Interest Coverage Ratio rose 69.99% year-over-year to 2.46; the trailing twelve-month figure through Dec 2025 stood at 22.95 (up 51.34% YoY), and the FY2025 full-year result was 0.58, up 44.41% from the prior year.
- Interest Coverage Ratio retreated to 2.46 in Q3 2025, from 0.15 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 278.4 in Q4 2023 to a low of 190.78 in Q4 2022.
- A 5-year average of 15.04 and a median of 8.19 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 11254.32% in 2022 and surged 245.92% in 2023, its largest moves.
- Tracing STRO's Interest Coverage Ratio over 5 years: stood at 17.93 in 2021, then tumbled by 1164.02% to 190.78 in 2022, then surged by 245.92% to 278.4 in 2023, then plunged by 110.19% to 28.37 in 2024, then jumped by 91.33% to 2.46 in 2025.
- Business Quant data shows STRO's Interest Coverage Ratio at 2.46 in Q3 2025, 0.15 in Q2 2025, and 29.79 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.46 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -29.79 |
| Dec 31, 2024 | -28.37 |
| Sep 30, 2024 | -8.19 |
| Jun 30, 2024 | -5.87 |
| Mar 31, 2024 | -24.60 |
| Dec 31, 2023 | 278.40 |
| Sep 30, 2023 | -146.71 |
| Jun 30, 2023 | -1.14 |
| Mar 31, 2023 | -24.85 |
| Dec 31, 2022 | -190.78 |
| Sep 30, 2022 | -7.61 |
| Jun 30, 2022 | -32.30 |
| Mar 31, 2022 | -55.90 |
| Dec 31, 2021 | 17.93 |
| Sep 30, 2021 | -0.97 |
| Jun 30, 2021 | -0.28 |
| Mar 31, 2021 | -22.16 |
| Dec 31, 2020 | -21.89 |